ArticleFrontiers in neurology2022

Metabolomics of Cerebrospinal Fluid in Multiple Sclerosis Compared With Healthy Controls: A Pilot Study.

Michal Židó et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.